Go Pro

Modular Medical (MODD) Competitors

Modular Medical logo
$3.46 -0.15 (-4.16%)
As of 08/28/2026 04:00 PM Eastern

MODD vs. CVRX, NNOX, NYXH, HSAQ, and DXR

Should you buy Modular Medical stock or one of its competitors? Modular Medical's main competitors and comparable companies include CVRx (CVRX), Nano-X Imaging (NNOX), Nyxoah (NYXH), Health Sciences Acquisitions Co. 2 (HSAQ), and Daxor (DXR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Modular Medical compare to CVRx?

CVRx (NASDAQ:CVRX) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

CVRx has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 7.1% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-84.93% -152.35% -50.93%
Modular Medical N/A -292.14%-222.79%

CVRx currently has a consensus price target of $5.30, indicating a potential upside of 79.66%. Given CVRx's stronger consensus rating and higher possible upside, research analysts plainly believe CVRx is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Modular Medical has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$56.65M1.39-$53.31M-$1.98N/A
Modular MedicalN/AN/A-$28.24M-$8.69N/A

In the previous week, CVRx had 5 more articles in the media than Modular Medical. MarketBeat recorded 7 mentions for CVRx and 2 mentions for Modular Medical. CVRx's average media sentiment score of 0.31 beat Modular Medical's score of 0.30 indicating that CVRx is being referred to more favorably in the media.

Company Overall Sentiment
CVRx Neutral
Modular Medical Neutral

Summary

CVRx beats Modular Medical on 12 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Modular Medical has lower revenue, but higher earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$14.52M4.49-$75.02M-$1.58N/A
Modular MedicalN/AN/A-$28.24M-$8.69N/A

In the previous week, Nano-X Imaging had 4 more articles in the media than Modular Medical. MarketBeat recorded 6 mentions for Nano-X Imaging and 2 mentions for Modular Medical. Nano-X Imaging's average media sentiment score of 0.48 beat Modular Medical's score of 0.30 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company Overall Sentiment
Nano-X Imaging Neutral
Modular Medical Neutral

Modular Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-716.44% -70.96% -62.26%
Modular Medical N/A -292.14%-222.79%

Nano-X Imaging has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market.

Nano-X Imaging currently has a consensus price target of $4.33, indicating a potential upside of 422.34%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Nano-X Imaging beats Modular Medical on 12 of the 16 factors compared between the two stocks.

How does Modular Medical compare to Nyxoah?

Modular Medical (NASDAQ:MODD) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

In the previous week, Modular Medical and Modular Medical both had 2 articles in the media. Nyxoah's average media sentiment score of 1.28 beat Modular Medical's score of 0.30 indicating that Nyxoah is being referred to more favorably in the news media.

Company Overall Sentiment
Modular Medical Neutral
Nyxoah Positive

Modular Medical has higher earnings, but lower revenue than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$28.24M-$8.69N/A
Nyxoah$11.33M5.47-$101.92M-$2.52N/A

Nyxoah has a consensus target price of $4.26, indicating a potential upside of 166.38%. Given Nyxoah's stronger consensus rating and higher possible upside, analysts plainly believe Nyxoah is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nyxoah
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Modular Medical has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.62, indicating that its share price is 62% more volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Nyxoah's net margin of -443.16%. Nyxoah's return on equity of -178.90% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -292.14% -222.79%
Nyxoah -443.16%-178.90%-81.83%

27.5% of Modular Medical shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Nyxoah beats Modular Medical on 10 of the 14 factors compared between the two stocks.

How does Modular Medical compare to Health Sciences Acquisitions Co. 2?

Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A
Modular MedicalN/AN/A-$28.24M-$8.69N/A

In the previous week, Modular Medical had 2 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 2 mentions for Modular Medical and 0 mentions for Health Sciences Acquisitions Co. 2. Modular Medical's average media sentiment score of 0.30 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Health Sciences Acquisitions Co. 2 Neutral
Modular Medical Neutral

Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Sciences Acquisitions Co. 2
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Sciences Acquisitions Co. 2N/A N/A -2.38%
Modular Medical N/A -292.14%-222.79%

Summary

Health Sciences Acquisitions Co. 2 beats Modular Medical on 5 of the 9 factors compared between the two stocks.

How does Modular Medical compare to Daxor?

Modular Medical (NASDAQ:MODD) and Daxor (NASDAQ:DXR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

Daxor's return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -292.14% -222.79%
Daxor N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Daxor
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Modular Medical had 1 more articles in the media than Daxor. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Daxor. Daxor's average media sentiment score of 1.89 beat Modular Medical's score of 0.30 indicating that Daxor is being referred to more favorably in the news media.

Company Overall Sentiment
Modular Medical Neutral
Daxor Very Positive

Daxor has higher revenue and earnings than Modular Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$28.24M-$8.69N/A
Daxor$10.30M5.78N/AN/AN/A

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by insiders. Comparatively, 51.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Modular Medical has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market. Comparatively, Daxor has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market.

Summary

Daxor beats Modular Medical on 7 of the 10 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MODD vs. The Competition

MetricModular MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$28.20M$5.82B$7.20B$12.90B
Dividend YieldN/A1.75%2.54%11.28%
P/E Ratio-0.4025.92273.1625.45
Price / SalesN/A68.01604.4876.58
Price / CashN/A33.0376.7453.00
Price / Book2.626.1812.986.14
Net Income-$28.24M$149.01M$3.48B$348.86M
7 Day Performance-2.26%-0.24%0.13%-0.80%
1 Month Performance67.15%6.18%7.08%4.13%
1 Year Performance-84.04%6.30%24.67%15.17%

Modular Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MODD
Modular Medical
0.2755 of 5 stars
$3.46
-4.2%
N/A-84.0%$28.20MN/AN/A20
CVRX
CVRx
3.7505 of 5 stars
$2.82
+2.5%
$5.30
+87.9%
-62.4%$75.13M$56.65MN/A160
NNOX
Nano-X Imaging
4.2511 of 5 stars
$0.93
+4.9%
$4.33
+365.9%
-78.6%$65.16M$13.02MN/A190
NYXH
Nyxoah
2.9483 of 5 stars
$1.65
+3.1%
$4.26
+158.3%
-74.4%$63.95M$11.33MN/A110
HSAQ
Health Sciences Acquisitions Co. 2
N/A$5.66
+19.9%
N/A+91.3%$63.46MN/AN/A4

Related Companies and Tools


This page (NASDAQ:MODD) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners